Identification and management of women with inherited bleeding disorders: A survey of obstetricians and gynaecologists in the United Kingdom

Haemophilia

Volumn 12, Issue 4, 2006, Pages 405-412

  Chi, C ^a   Shiltagh, N ^a   Kingman, C E C ^a   Economides, D L ^a   Lee, C A ^a   Kadir, R A ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

Carriers of haemophilia; Inherited bleeding disorders; Menorrhagia; Pregnancy; von Willebrand's disease

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BLOOD CLOTTING DISORDER; CLINICAL COMPETENCE; CLINICAL TRIAL; DELIVERY; EPIDEMIOLOGY; FEMALE; FETUS DISEASE; HEMOPHILIA A; HETEROZYGOTE; HUMAN; MEDICAL STAFF; MENORRHAGIA; METHODOLOGY; MULTICENTER STUDY; POSTPARTUM HEMORRHAGE; PREGNANCY; PREGNANCY COMPLICATION; PRENATAL DIAGNOSIS; PROFESSIONAL PRACTICE; STANDARD; STATISTICS; UNITED KINGDOM; VON WILLEBRAND DISEASE;

ADOLESCENT; ADULT; BLOOD COAGULATION DISORDERS, INHERITED; CLINICAL COMPETENCE; DELIVERY, OBSTETRIC; FEMALE; FETAL DISEASES; GREAT BRITAIN; HEALTH CARE SURVEYS; HEMOPHILIA A; HETEROZYGOTE; HUMANS; MEDICAL STAFF, HOSPITAL; MENORRHAGIA; POSTPARTUM HEMORRHAGE; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; PRENATAL DIAGNOSIS; PROFESSIONAL PRACTICE; VON WILLEBRAND DISEASE;

EID: 33749032464     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/j.1365-2516.2006.01282.x     Document Type: Article

References (54)

1. Shankar M, Lee CA, Sabin CA, Economides DL, Kadir RA. Von Willebrand disease in women with menorrhagia: a systemic review. BJOG 2004; 111: 734-740.
2. James A, Matchar DB, Myers ER. Testing for von Willebrand disease in women with menorrhagia: a systematic review. Obstet Gynecol 2004; 104: 381-388.
3. Rodeghiero F, Castaman G, Dini E. Epidemiological investigation of the prevalence of von Willebrand's disease. Blood 1987; 69: 454-459.
4. Werner EJ, Broxson EH, Tucker EL, Girioux DS, Shults J, Abshire TC. Prevalence of von Willebrand disease in children: a multiethnic study. J Pediatr 1993; 123: 893-898.
5. Kadir RA, Economides DL, Sabin CA, Pollard D and Lee CA. Assessment of menstrual blood loss and gynaecological problems in patients with inherited bleeding disorders. Haemophilia 1999; 5: 40-48.
6. Silwer J. Willebrand's disease in Sweden. Acta Paediatr Scand Suppl 1973; 238: 1-159.
7. Kouides PA, Phatak PD, Burkart P et al. Gynaecological and obstetrical morbidity in women with type I von Willebrand's disease: results of a patient survey. Haemophilia 2000; 6: 643-648.
8. Kadir RA, Lee CA, Sabin CA, Pollard D, Economides DL. Pregnancy in women with von Willebrand's disease or factor XI deficiency. BJOG 1998; 105: 314-321.
9. Greer IA, Lowe GD, Walker JJ and Forbes CD. Haemorrhagic problems in obstetrics and gynaecology in patients with congenital coagulopathies. BJOG 1991; 98: 909-918.
10. Ramsahoye BH, Davies SV, Dasani H, Pearson JF. Obstetrics management in von Willebrand's disease: a report of 24 pregnancies and a review of the literature. Haemophilia 1995; 1: 140-144.
11. Oehler MK, Rees MC. Menorrhagia: an update. Acta Obstet Gynecol Scand 2003; 82: 405-422.
12. Corrado M. Women's Health in 1990. London: Market & Opinion Research International, 1990.
13. Royal College of General Practitioners, Office of Population Censuses and Surveys. Morbidity Statistics from General Practice 1981-1982. London: HMSO, 1986.
14. Warner P, Critchley HO, Lumsden MA, Campbell-Brown M, Douglas A, Murray G. Referral for menstrual problems. Cross sectional survey of symptoms, reasons for referral and management. BMJ 2001; 323: 24-28.
15. Rees M. Menorrhagia. BMJ 1987; 294: 759-762.
16. Dilley A, Drews C, Lally C, Austin H, Barnhart E, Evatt B. A survey of gynaecologists concerning menorrhagia: perceptions of bleeding disorders as a possible cause. J Women's Health Gender Based Med 2002; 11: 39-44.
17. Philipp CS, Faiz A, Dowling N et al. Age and the Prevalence of bleeding disorders in women with menorrhagia. Obstet Gynecol 2005; 105: 61-66.
18. Smith YR, Quint EH, Hertzberg RB. Menorrhagia in adolescents requiring hospitalisation. J Pediatr Adolesc Gynecol 1998; 11: 13-15.
19. Oral E, Cagdas A, Gezer A, Kaleli S, Aydin Y, Ocer F. Hematological abnormalities in adolescent menorrhagia. Arch Gynecol Obstet 2002; 266: 72-74.
20. Kadir RA, Economides DL, Sabin CA, Owens D, Lee CA. Frequency of inherited bleeding disorders in women with menorrhagia. Lancet 1998; 351: 485-489.
21. Ragni MV, Bontempo FA, Hassett AC. Willebrand disease and bleeding in women. Haemophilia 1999; 5: 313-317.
22. Royal College of Obstetricians and Gynaecologists. Evidence-based Guidelines No 5: The Management of Menorrhagia in Secondary Care. London: RCOG Press, 1999.
23. Cunningham FG, Macdonald PC, Gant NF. Abnormalities of the third stage of labour. In: Cunningham FG, Macdonald PC, Gant NF, eds. William's Obstetrics. London: Prentice-Hall, 1989: 415-424.
24. Lee CY, Madrazo B, Drukker BH. Ultrasonic evaluation of the postpartum uterus in the management of postpartum bleeding. Obstet Gynecol 1981; 58: 227-232.
25. Kadir RA, Economides DL, Braithwaite J, Goldman E, Lee CA. The obstetric experience of carriers of haemophilia. BJOG 1997; 104: 803-810.
26. Cash JD, Gader AMA, Da Costa J. The release of plasminogen activator and factor VIII by LVP, AVP, DDAVP, AT III and OT in man. Br J Haematol 1974; 27: 363-364.
27. Mannucci PM, Aberg M, Nilsson IM, Robertson B. Mechanism of plasminogen activator and factor VIII increase after vasoactive drugs. Br J Haematol 1975; 30: 81-93.
28. Sakariassen KS, Cattaneo M, van den Berg A, Ruggeri ZM, Mannucci PM, Sixma JJ. DDAVPenhances platelet adherence and platelet aggregate growth on human artery subendothelium. Blood 1984; 64: 229-236.
29. Mannucci PM, Ruggeri ZM, Pareti FI, Capitanio A. 1-deamino-8-d-arginine vasopressin: a new pharmacological approach to the management of haemophilia and von Willebrand's diseases. Lancet 1977; 1: 1869-1872.
30. Mannucci PM, Canciani MT, Rota L, Donovan BS. Response of factor VIII/von Willebrand factor to DDAVP in healthy subjects and patients with hemophilia A and von Willebrand's disease. Br J Haematol 1981; 47: 283-293.
31. Kobrinsky NL, Israels ED, Gerrard MJ et al. Shortening of the bleeding disorders. Lancet 1984; 1: 1145-1148.
32. Winckelman G, Augustin R. Improvement of primary hemostasis by DDAVP in patients with various platelet defects. Thromb Haemost 1985; 54: 12.
33. Lethagen S, Ragnarson Tennvall G. Self-treatment with desmopressin intranasal spray in patients with bleeding disorders: effect on bleeding symptoms and socio-economic factors. Ann Hematol 1993; 66: 257-260.
34. Kouides PA. Obstetric and gynaecological aspects of von willebrand disease. Best Pract Res Clin Haematol 2001; 14: 381-399.
35. Mannucci PM. Desmopressin: a nontransfusional form of treatment for congenital and acquired bleeding disorders. Blood 1988; 72: 1449-1455.
36. Manucci PM. Desmopressin (DDAVP) in the treatment of bleeding disorders: the first 20 years. Blood 1997; 90: 2515-2521.
37. Cohen AJ, Kessler CM, Ewenstein BM. Management of von Willebrand disease: a survey on current clinical practice from the haemophilia centres of North America. Haemophilia 2001; 7: 235-241.
38. Ray JG. DDAVP use during pregnancy: an analysis of its safety for mother and child. Obstet Gynecol Surv 1998; 53: 450-455.
39. Mannucci PM. Use of desmopressin (DDAVP) during early pregnancy in factor VIII-deficient women. Letter to the editor. Blood 2005; 105: 3382.
40. Economides DL, Kadir RA, Lee CA. Inherited bleeding disorders in obstetrics and gynaecology. BJOG 1999; 106: 5-13.
41. Rhoads GG, Jackson LG, Schlesselman SE et al. The safety and efficacy of chorionic villus sampling for early prenatal diagnosis of cytogenetic abnormalities. N Engl J Med 1989; 320: 609-617.
42. Wilson RD, Farquharson DF, Wittmann BK, Shaw D. Cordocentesis: overall pregnancy loss rate as important as procedure loss rate. Fetal Diagn Ther 1994; 9: 142-148.
43. Efrat Z, Akinfenwa OO, Nicolaides KH. First trimester determination of fetal gender by ultrasound. Ultrasound Obstet Gynecol 1999; 13: 305-307.
44. Whitlow BJ, Lazanakis MS, Economides DL. The sonographic identification of fetal gender from 11-weeks of gestation. Ultrasound Obstet Gynecol 1999; 13: 301-304.
45. Lo YMD, Corbetta N, Chamberlain PF, et al. Presence of fetal DNA in maternal plasma and serum. Lancet 1997; 350: 485-487.
46. Honda H, Miharu N, Ohasi Y et al. Fetal gender determination in early pregnancy through qualitative and quantitative analysis of fetal DNA in maternal serum. Hum Genet 2002; 110: 75-79.
47. Rijnders RJ, Van Der Luijt RB, Peters ED et al. Earliest gestational age for fetal sexing in cell-free maternal plasma. Prenat Diagn 2003; 23: 1042-1044.
48. Lavery S. Preimplantation genetic diagnosis: new reproductive options for carriers of haemophilia. Haemophilia 2004; 10, (Suppl. 4): 126-132.
49. Handyside AH, Pattinson JK, Penketh RJ, Delhanty JD, Winston RM, Tuddenham EG. Biopsy of human preimplantation embryos and sexing by DNA amplification. Lancet 1989; 18: 347-349.
50. Ljung R, Lindgren AC, Petrini P et al. Normal vaginal delivery is to be recommended for haemophilia carrier gravidae. Acta Paediatr 1994; 83: 6901-6911.
51. Kulkarni R, Lusher JM, Henry RC, Kallen DJ. Current practices regarding newborn intracranial haemorrhage and obstetrical care and mode of delivery of pregnant haemophilia carriers: a survey of obstetricians, neonatologists and haematologists in the United States, on behalf of the National Hemophilia Foundation's Medical and Scientific Advisory Council. Haemophilia 1999; 5: 410-415.
52. Kadir RA, Sabin CA, Pollard D, Lee CA, Economides Quality of life during menstruation in patients with inherited bleeding disorders. Haemophilia 1998; 4: 836-841.
53. Soucie JM, Nuss R, Evatt B et al. and the Hemophilia Surveillance System Project Investigators Mortality among males with hemophilia: relations with source of medical care. Blood 2000; 96: 437-442.
54. Kirtava A, Crudder S, Dilley A. Trends in clinical management of women with von Willebrand disease: a survey of 75 women enrolled in haemophilia treatment centres in the United States. Haemophilia 2004; 10: 158-161.